title: Immunocalins: a lipocalin subfamily that modulates immune and inflammatory responses.
abstract: A subset of the lipocalins, notably alpha(1)-acid glycoprotein, alpha(1)-microglobulin, and glycodelin, exert significant immunomodulatory effects in vitro. Interestingly, all three are encoded from the q32-34 region of human chromosome 9, together with at least four other lipocalins (neutrophil gelatinase-associated lipocalin, complement factor gamma-subunit, tear prealbumin, and prostaglandin D synthase) that also may have anti-inflammatory and/or antimicrobial activity. This review addresses important features of this genetically linked subfamily of lipocalins (involvement with the acute phase response, immunomodulatory and anti-inflammatory properties, the tissue localization, complex formation with other proteins and receptors, etc.). It is likely that these proteins have evolved to be an integrated part of the body's defense system as part of the extended cytokine network. Its members exert a regulatory, dampening influence on the inflammatory cascade, thereby protecting against tissue damage from excessive inflammation. That most major mammalian allergens are lipocalins may reflect this connection of lipocalins with the immune system. We propose that this immunologically active lipocalin subset be named the 'immunocalins', signifying not only the structural homology and close genetic linkage of its members, but also their protective involvement with immunological and inflammatory processes. As immune mediators, immunocalins appear to use at least three interactive sites: the lipocalin 'pocket', binding sites for other plasma proteins, and binding sites for cell surface receptors.
authors.affiliation: Laboratory of Stem Cell Biology, New York Blood Center, NY 10021, USA. logdberg@nybc.org
authors.forename: L
authors.initials: L
authors.lastname: Lögdberg
authors.forename: L
authors.initials: L
authors.lastname: Wester
mesh_terms: D000210:Acute-Phase Reaction; D000276:Adjuvants, Immunologic; D000818:Animals; D000890:Anti-Infective Agents / Q000276:immunology; D000893:Anti-Inflammatory Agents / Q000276:immunology; D000071816:Glycodelin; D006023:Glycoproteins / Q000276:immunology*; D006801:Humans; D006967:Hypersensitivity / Q000378:metabolism; D008562:Membrane Glycoproteins / Q000276:immunology*; D009961:Orosomucoid / Q000276:immunology*; D011257:Pregnancy Proteins / Q000276:immunology*; D011956:Receptors, Cell Surface / Q000378:metabolism; D014360:Trypsin Inhibitor, Kunitz Soybean
chemical_list: D000276:Adjuvants, Immunologic; D000890:Anti-Infective Agents; D000893:Anti-Inflammatory Agents; D000071816:Glycodelin; D006023:Glycoproteins; D008562:Membrane Glycoproteins; D009961:Orosomucoid; C045246:PAEP protein, human; D011257:Pregnancy Proteins; D011956:Receptors, Cell Surface; C109148:SPINT2 protein, human; D014360:Trypsin Inhibitor, Kunitz Soybean